Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | ARS: Annual Report to Security Holders
Aclaris Therapeutics | DEFA14A: Others
Aclaris Therapeutics | DEF 14A: Definitive information statements
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 8-K: Current report
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Balthaser Kevin
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Monahan Joseph
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal
Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Powell Andrew Kenneth William
Aclaris Therapeutics | 10-K: Annual report
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%), etc.
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(7.6%),Citadel Advisors LLC(6.1%), etc.
Aclaris Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%), etc.
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(2.5%),Tang Capital Management, LLC(2.5%), etc.
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(4.23%),Rock Springs Capital LLC(4.23%), etc.
Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Aclaris Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(6.67%)
No Data